Dhaka Stock Exchange
DSE stocks: valuation and dividends
Data as of 29 Oct 2026 close (DSE).
Median P/E of profitable DSE stocks is 19.7 and median P/B is 1.09; 132 of 358 have no P/E (losses or no recent earnings). 273 pay a dividend, median yield 1.90%; highest: EXIMBANK 33.33%, NEWLINE 26.06%, SHURWID 21.28%. Very high yields often follow a price fall or a one-off dividend; check the payout ratio.
Filter by sector: Health Technology
All · Commercial Services · Communications · Consumer Durables · Consumer Non-Durables · Consumer Services · Distribution Services · Electronic Technology · Energy Minerals · Finance · Health Services · Health Technology · Industrial Services · Non-Energy Minerals · Process Industries · Producer Manufacturing · Retail Trade · Technology Services · Transportation · Utilities| Stock | Company | Sector | Price | Market cap (৳ crore) | P/E | P/B | P/S | Dividend yield | Payout ratio |
|---|---|---|---|---|---|---|---|---|---|
| SQURPHARMA | Square Pharmaceuticals PLC. | Health Technology | 217.90 | 19,315.77 | 7.47 | 1.28 | 2.31 | 5.51% | 40.97% |
| BXPHARMA | Beximco Pharmaceuticals PLC. | Health Technology | 144.30 | 6,437.40 | 7.44 | 1.00 | 1.19 | 3.29% | 2.45% |
| RENATA | Renata PLC | Health Technology | 425.70 | 4,882.63 | 13.40 | 1.19 | 1.06 | 1.29% | 17.45% |
| UNILEVERCL | Unilever Consumer Care Limited | Health Technology | 1,880.00 | 3,623.57 | 71.08 | 20.18 | 11.01 | 2.15% | 152.75% |
| BEACONPHAR | Beacon Pharmaceuticals PLC | Health Technology | 91.50 | 2,141.37 | 14.70 | 2.76 | 1.38 | 2.27% | 18.46% |
| ACMELAB | The ACME Laboratories Ltd. | Health Technology | 77.60 | 1,648.38 | 6.18 | 0.59 | 0.41 | 4.49% | 27.80% |
| ACI | Advanced Chemical Industries PLC. | Health Technology | 177.70 | 1,560.77 | 1.72 | 0.10 | 1.41% | ||
| ASIATICLAB | Asiatic Laboratories Limited | Health Technology | 106.70 | 1,305.94 | 24.58 | 1.88 | 4.55 | 0.94% | 10.53% |
| IBNSINA | The IBN SINA Pharmaceutical Industry PLC | Health Technology | 297.50 | 929.50 | 11.70 | 1.97 | 0.66 | 2.59% | 26.93% |
| NAVANAPHAR | Navana Pharmaceuticals PLC | Health Technology | 60.20 | 646.65 | 10.74 | 1.20 | 0.60 | 2.33% | 8.47% |
| ORIONPHARM | Orion Pharma Limited | Health Technology | 27.30 | 638.82 | 0.31 | 2.20 | 0.00% | ||
| JHRML | JMI Hospital Requisite Manufacturing Limited | Health Technology | 36.70 | 482.38 | 39.46 | 1.02 | 3.03 | 1.30% | 38.09% |
| ORIONINFU | Orion Infusion Limited | Health Technology | 213.60 | 462.57 | 130.26 | 14.01 | 7.14 | 0.88% | 128.43% |
| TECHNODRUG | Techno Drugs Ltd. | Health Technology | 33.90 | 455.39 | 22.50 | 1.10 | 1.47 | 2.90% | 21.17% |
| JMISMDL | JMI Syringes & Medical Devices Limited | Health Technology | 123.10 | 386.22 | 1.54 | 2.31 | 0.78% | ||
| AMBEEPHA | Ambee Pharmaceuticals PLC | Health Technology | 727.80 | 175.37 | 317.27 | 49.60 | 11.13 | 0.14% | 39.37% |
| IBP | Indo-Bangla Pharmaceuticals Limited | Health Technology | 13.00 | 152.23 | 1.04 | 6.29 | 0.11% | ||
| SILCOPHL | Silco Pharmaceuticals Limited | Health Technology | 14.50 | 150.52 | 43.82 | 0.64 | 3.76 | 0.76% | 23.68% |
| SILVAPHL | Silva Pharmaceuticals Limited | Health Technology | 10.20 | 140.59 | 0.70 | 4.27 | 0.10% | ||
| LIBRAINFU | Libra Infusions Limited | Health Technology | 555.90 | 125.24 | 790.56 | 0.71 | 6.86 | 0.18% | 0.58% |
| ADVENT | Advent Pharma Ltd. | Health Technology | 13.20 | 121.07 | 25.05 | 0.78 | 2.64 | 0.38% | 4.29% |
| ACTIVEFINE | Active Fine Chemicals Limited | Health Technology | 4.50 | 105.57 | 0.20 | 0.78 | 0.57% | ||
| CENTRALPHL | Central Pharmaceuticals Ltd. | Health Technology | 8.30 | 99.43 | 1.22 | 27.55 | 0.00% | ||
| DESHBANDHU | Deshbandhu Polymer Limited | Health Technology | 12.90 | 79.16 | 1.11 | 7.56 | 0.00% | ||
| AFCAGRO | AFC Agro Biotech Limited | Health Technology | 4.90 | 55.30 | 698.28 | 0.26 | 1.27 | 1.04% | 101.07% |
- Price: Last close.
- P/E: Price ÷ trailing 12-month EPS.
- P/B: Price ÷ book value per share (latest quarter).
- P/S: Market cap ÷ trailing 12-month revenue.
- Dividend yield: Trailing dividends ÷ price.
- Payout ratio: Dividends ÷ earnings, trailing 12 months.
- Facts only, not investment advice. Data: AnalystBro, exchange disclosures.